FDAsafety guidance72% confidence
Drug Trials Snapshots
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (immunology) as AbbVie.
Regulatory Analysis
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots are part of an overall FDA effort to make demographic data more available and transparent.
Supporting Context
- Therapeutic area
- Dermatology · Atopic Dermatitis
- Sub-indication
- Immunology
Related signal: AbbVie Trials Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Dupilumab Inadequate Responders